Clint A. Stalnecker

4.4k total citations
19 papers, 404 citations indexed

About

Clint A. Stalnecker is a scholar working on Molecular Biology, Cancer Research and Biotechnology. According to data from OpenAlex, Clint A. Stalnecker has authored 19 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Cancer Research and 5 papers in Biotechnology. Recurrent topics in Clint A. Stalnecker's work include Cancer, Hypoxia, and Metabolism (11 papers), Cancer Research and Treatments (5 papers) and Glycosylation and Glycoproteins Research (2 papers). Clint A. Stalnecker is often cited by papers focused on Cancer, Hypoxia, and Metabolism (11 papers), Cancer Research and Treatments (5 papers) and Glycosylation and Glycoproteins Research (2 papers). Clint A. Stalnecker collaborates with scholars based in United States, India and Norway. Clint A. Stalnecker's co-authors include Channing J. Der, Richard A. Cerione, Jon W. Erickson, Chengliang Zhang, Sekar Ramachandran, Yunxing Li, William P. Katt, Qingqiu Huang, Ralph J. DeBerardinis and Scott M. Ulrich and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Clint A. Stalnecker

18 papers receiving 402 citations

Peers

Countries citing papers authored by Clint A. Stalnecker

Since Specialization

Citations

This map shows the geographic impact of Clint A. Stalnecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clint A. Stalnecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clint A. Stalnecker more than expected).

Fields of papers citing papers by Clint A. Stalnecker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clint A. Stalnecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clint A. Stalnecker. The network helps show where Clint A. Stalnecker may publish in the future.

Co-authorship network of co-authors of Clint A. Stalnecker

This figure shows the co-authorship network connecting the top 25 collaborators of Clint A. Stalnecker. A scholar is included among the top collaborators of Clint A. Stalnecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clint A. Stalnecker. Clint A. Stalnecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Abstract 5507: Mechanisms of resistance to RAS-GTP inhibition in pancreatic cancer 2025 ·Cancer Research ·(unknown), Julien Dilly, Eejung Kim, Lo Lai, (unknown), (unknown), (unknown), (unknown), Brendan Parent, Junning Wang, Kyle J. Seamon, Jennifer A. Chan, Clint A. Stalnecker, Channing J. Der, William L. Hwang, Brian M. Wolpin, David Wildes, Joseph D. Mancias, Lewis C. Cantley, Andrew J. Aguirre	1
2	Abstract 4588: Combination of MTA-cooperative PRMT5 inhibitor and direct mutant-selective KRAS inhibitors as a novel therapeutic approach for MTAP-deficient pancreatic cancer 2024 ·Cancer Research ·Kristina Drizyte‐Miller, (unknown), Andrew M. Waters, Clint A. Stalnecker, Junning Wang, Andrew J. Aguirre, Adrienne D. Cox, Channing J. Der	2
3	TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors 2023 ·Cancer Research ·A. Cole Edwards, Clint A. Stalnecker, (unknown), (unknown), Jennifer E. Klomp, Jeffrey A. Klomp, Andrew M. Waters, Niranjan Sudhakar, Jill Hallin, (unknown), Peter Olson, Leonard Post, James G. Christensen, Adrienne D. Cox, Channing J. Der	33
4	Abstract 1075: Identification of resistance mechanisms to direct KRAS inhibition in pancreatic cancer 2023 ·Cancer Research ·Andrew M. Waters, (unknown), Clint A. Stalnecker, (unknown), Runying Yang, Craig M. Goodwin, Adrienne D. Cox, Channing J. Der	1
5	Abstract B009: TEAD inhibition overcomes YAP1/TAZ-driven resistance to RAS inhibitors in KRASG12C-mutant cancers 2023 ·Molecular Cancer Research ·A. Cole Edwards, Clint A. Stalnecker, (unknown), (unknown), Jill Hallin, (unknown), (unknown), Lars D. Engstrom, (unknown), James G. Christensen, Adrienne D. Cox, Channing J. Der	0
6	VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in KRAS-mutant pancreatic cancer 2023 ·Genes & Cancer ·(unknown), Jennifer E. Klomp, Clint A. Stalnecker, Craig M. Goodwin, Yanzhe Gao, (unknown), Cyrus Vaziri, Kirsten L. Bryant, Channing J. Der, Adrienne D. Cox	5
7	Detection of phenotype‐specific therapeutic vulnerabilities in breast cells using a CRISPR loss‐of‐function screen 2021 ·Molecular Oncology ·Anna Barkovskaya, Craig M. Goodwin, (unknown), Bylgja Hilmarsdóttir, Solveig Pettersen, Clint A. Stalnecker, Olav Engebraaten, Eiríkur Briem, Channing J. Der, Siver Andreas Moestue, Þórarinn Guðjónsson, Gunhild M. Mælandsmo, Lina Prasmickaite	4
8	The activation loop and substrate-binding cleft of glutaminase C are allosterically coupled 2020 ·Journal of Biological Chemistry ·Yunxing Li, Sekar Ramachandran, (unknown), Clint A. Stalnecker, Richard A. Cerione, Jon W. Erickson	5
9	RAS, wanted dead or alive: Advances in targeting RAS mutant cancers 2020 ·Science Signaling ·Clint A. Stalnecker, Channing J. Der	66
10	SIRT5 stabilizes mitochondrial glutaminase and supports breast cancer tumorigenesis 2019 ·Proceedings of the National Academy of Sciences ·Kai Su Greene, Michael J. Lukey, Xueying Wang, Bryant S. Blank, Joseph E. Druso, Miao-chong J. Lin, Clint A. Stalnecker, Chengliang Zhang, (unknown), Jon W. Erickson, Kristin F. Wilson, Hening Lin, Robert S. Weiss, Richard A. Cerione	94
11	The activation loop and substrate-binding cleft of glutaminase C are allosterically coupled 2019 ·Journal of Biological Chemistry ·Yunxing Li, Sekar Ramachandran, (unknown), Clint A. Stalnecker, Richard A. Cerione, Jon W. Erickson	2
12	Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism 2018 ·Journal of Biological Chemistry ·Qingqiu Huang, Clint A. Stalnecker, Chengliang Zhang, Lee McDermott, (unknown), Jason O’Neill, (unknown), Richard A. Cerione, William P. Katt	68
13	Conformational changes in the activation loop of mitochondrial glutaminase C: A direct fluorescence readout that distinguishes the binding of allosteric inhibitors from activators 2017 ·Journal of Biological Chemistry ·Clint A. Stalnecker, Jon W. Erickson, Richard A. Cerione	17
14	Balancing redox stress: anchorage-independent growth requires reductive carboxylation 2016 ·Translational Cancer Research ·Clint A. Stalnecker, Ahmad A. Cluntun, Richard A. Cerione	4
15	Fluorination at the 4 position alters the substrate behavior of l-glutamine and l-glutamate: Implications for positron emission tomography of neoplasias 2016 ·Journal of Fluorine Chemistry ·Thomas M. Jeitner, (unknown), (unknown), John T. Pinto, Clint A. Stalnecker, Jon W. Erickson, Hank F. Kung, Jianyong Li, Karl Plöessl, Arthur J.L. Cooper	5
16	Mechanistic Basis of Glutaminase Activation 2016 ·Journal of Biological Chemistry ·Yunxing Li, Jon W. Erickson, Clint A. Stalnecker, William P. Katt, Qingqiu Huang, Richard A. Cerione, Sekar Ramachandran	24
17	Targeting Altered Cancer Cell Metabolism: Mitochondrial Glutaminase Regulation And Inhibition By Small Molecules 2016 ·eCommons (Cornell University) ·Clint A. Stalnecker	1
18	Mechanism by which a recently discovered allosteric inhibitor blocks glutamine metabolism in transformed cells 2014 ·Proceedings of the National Academy of Sciences ·Clint A. Stalnecker, Scott M. Ulrich, Yunxing Li, Sekar Ramachandran, Mary Kate McBrayer, Ralph J. DeBerardinis, Richard A. Cerione, Jon W. Erickson	71
19	Abstract C42: Mitochondrial glutaminase regulation and small molecule inhibition of glutamine metabolism 2013 ·Cancer Research ·Clint A. Stalnecker, Jon W. Erickson, Sekar Ramachandran, Ralph J. DeBerardinis, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact